Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in South Carolina: The Definitive Guide for Patients and Families

Finding out that the medical device implanted to help restore your body is actually causing it harm is a trauma that no woman in South Carolina should have to face alone. Whether you are a breast cancer survivor in Charleston who navigated a complex reconstruction, a prophylactic mastectomy patient in Columbia, or an aesthetic surgery patient in Greenville, we understand the profound sense of betrayal that comes with a defective medical device diagnosis. At Attorney911, also known as The Manginello Law Firm, PLLC, we have spent twenty-seven years fighting for victims of institutional negligence. Our managing partner, Ralph Manginello, and our dedicated team, including associate attorney Lupe Peña, provide the aggressive, hyper-scientific representation required to take on global device manufacturers.

If you are currently experiencing complications like chronic pain, redness, fluid collection, or a late-stage diagnosis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), the path forward can feel overwhelming. This guide is designed to provide you with the technical, legal, and medical clarity you need. We represent clients throughout South Carolina, from the Lowcountry to the Upstate, ensuring that every woman has access to the high-caliber legal resources usually reserved for major metropolitan hubs. Our firm is admitted to the United States District Court for the Southern District of Texas and has a proven track record in high-stakes litigation, including our current representation in the $10,000,000 Bermudez v. Pi Kappa Phi case. We bring that same intensity to defective medical device litigation. If you need immediate answers, we invite you to call us at 1-888-ATTY-911 for a confidential, no-obligation consultation.

Understanding the Devices: Mesh, ADM, and Scaffolds in South Carolina Breast Surgery

In South Carolina’s leading medical centers, such as the Medical University of South Carolina (MUSC) or Prisma Health, surgeons frequently use a variety of “internal bra” techniques to support breast implants or tissue expanders. These techniques rely on three primary categories of products: Acellular Dermal Matrix (ADM), bioabsorbable scaffolds, and synthetic mesh.

Acellular Dermal Matrix (ADM) is a biological material derived from either human cadaver skin or animal tissue (porcine or bovine). The manufacturer removes all cells that could cause a rejection, leaving a “scaffold” of collagen. Over time, your own cells are supposed to grow into this matrix. Common brands used in South Carolina include AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), Strattice, and AlloMax (Becton Dickinson).

Bioabsorbable Scaffolds are synthetic materials designed to provide temporary support and then slowly dissolve or “resorb” into the body. The most common material is poly-4-hydroxybutyrate (P4HB). The leading brand in this category is GalaFLEX, manufactured by Galatea Surgical (a subsidiary of Becton Dickinson, or BD). Another common resorbable product is Phasix Mesh. These products are often marketed to South Carolina surgeons as a way to provide “long-term reinforcement” during a breast lift or reconstruction.

Synthetic Mesh refers to permanent materials like polypropylene. While widely used in hernia repairs, these materials are often used “off-label” in South Carolina breast surgeries.

The critical fact we want every patient in South Carolina to understand is this: The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA. We cite the FDA’s own November 9, 2023, letter to healthcare providers, which explicitly identified BD products like GalaFLEX and Phasix as having no determined safety record for breast-specific applications. When these products fail, they can cause catastrophic results, ranging from reconstruction loss to systemic infection.

The FDA Regulatory Failure: Why Defective Devices Reach South Carolina Operating Rooms

Many South Carolina patients assume that if a device is used in a major hospital, the FDA must have “approved” it as safe. This is a dangerous misconception. Most of the devices currently causing harm entered the market through the 510(k) clearance pathway (21 USC §360c).

Under 510(k), a manufacturer does not have to prove a device is safe or effective through clinical trials. They only have to show it is “substantially equivalent” to a “predicate device” already on the market. In the case of GalaFLEX, the manufacturer cited a surgical suture as a predicate. This “predicate creep” allows materials never tested in breast tissue to be implanted in women throughout South Carolina. Because these devices are only “cleared” rather than “approved,” they are not protected by the same federal preemption shields that protect “PMA approved” devices (as established in Medtronic v. Lohr).

Our managing partner, Ralph Manginello, has spent nearly three decades analyzing these regulatory shortcuts. We know that manufacturers frequently push these products “off-label” to South Carolina surgeons, providing marketing materials and technique guides for procedures the FDA never authorized. When you work with us, we don’t just look at what happened in the operating room; we look at the regulatory deception that put the product there in the first place.

The Spectrum of Complications: From Red Breast Syndrome to BIA-ALCL

If you were treated at a facility in Columbia, Charleston, or Greenville and are now suffering, your symptoms likely fall into several specific clinical categories. We have analyzed the peer-reviewed literature and FDA Manufacturer and User Facility Device Experience (MAUDE) data—including specific reports like MDR identifiers 15631404 and 14831155—to understand exactly how these devices fail.

Red Breast Syndrome and Endotoxin Contaminants

Red Breast Syndrome is a noninfectious, sterile inflammation specific to ADM. Peer-reviewed research, such as the Nguyen et al. (2019) study, has linked this to bacterial endotoxins (lipopolysaccharides) that survive the sterilization process. Even though the device is technically “sterile,” the remaining endotoxins trigger a massive inflammatory response. If your breast reconstruction in South Carolina suddenly turned bright red without a fever or high white blood cell count, you may have been a victim of an endotoxin-contaminated ADM.

Bioabsorbable Scaffold Failures (GalaFLEX and Phasix)

GalaFLEX and Phasix are supposed to resorb within 18 to 24 months. However, many women in South Carolina report that the scaffold does not dissolve. Instead, it remains as a sharp, palpable mass that can erode through the skin (extrusion) or cause permanent nerve pain (intercostal neuralgia). In some cases, the scaffold fails prematurely, leading to a “bottoming out” or loss of reconstruction support.

BIA-ALCL and BIA-SCC: The Oncological Risk

One of the most severe risks associated with textured surfaces is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is a CD30-positive, ALK-negative T-cell lymphoma. As of 2025, over 1,600 cases have been reported globally. While the Allergan BIOCELL textured implant recall in July 2019 was a major turning point, many women in South Carolina still have these devices in their bodies today.

Furthermore, the FDA issued a safety communication in September 2022 (updated in March 2023) regarding Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). This is a rare but aggressive cancer that forms in the scar tissue capsule around the implant. Unlike ALCL, SCC has been found with both smooth and textured implants.

We represent South Carolina women facing these life-altering diagnoses, ensuring they have the resources needed for explant surgery, capsulectomy, and long-term oncology care. Call Ralph Manginello and Lupe Peña today at 1-888-ATTY-911 to discuss your medical history and legal options.

Accountability for South Carolina Patients: Who Can Be Sued?

In a defective medical device case, the primary target is almost always the manufacturer. Companies like Allergan (AbbVie), Becton Dickinson (BD), MTF Biologics, and Integra LifeSciences have a legal duty to warn both surgeons and patients about the known risks of their products. When they engage in off-label promotion or withhold adverse event data (as alleged by whistleblowers like Dr. Hooman Noorchashm), they can be held strictly liable for design and manufacturing defects.

However, the legal landscape in South Carolina involves navigating the Learned Intermediary Doctrine. This doctrine generally protects manufacturers if they provide “adequate warnings” to the prescribing surgeon. But we know that manufacturers often mislead South Carolina surgeons through aggressive sales tactics. Additionally, we look for exceptions, such as the direct-to-consumer advertising exception (similar to the Perez v. Wyeth precedent), where manufacturers marketed directly to patients through social media and brochures without disclosing the off-label nature of the mesh.

Our firm is uniquely positioned to handle these multi-defendant cases. In our current Bermudez v. Pi Kappa Phi litigation, we are suing thirteen separate defendants, including national organizations and major institutions. We apply this same “leave no stone unturned” philosophy to medical device litigation, targeting everyone from the manufacturer to the distributor.

The Statutes of Limitation in South Carolina (Palmetto State)

One of the most critical things we must discuss with our South Carolina clients is the timeline. In South Carolina, the statute of limitations for personal injury and product liability is generally three years from the date of injury. However, South Carolina also recognizes the Discovery Rule. This means the clock may not start ticking until you knew, or “reasonably should have known,” that your injury was caused by the defective mesh or scaffold.

For many women in South Carolina, the “discovery” date might be the November 2023 FDA letter or the date of a revision surgery where a doctor found an unabsorbed piece of GalaFLEX. However, South Carolina also has a Statute of Repose of eight years for certain types of claims, which acts as an absolute bar in some circumstances. Because these rules are complex and strictly enforced, you cannot afford to wait.

Case Precedents and What This Means for South Carolina Victims

While every case is different, and we cannot guarantee a specific outcome, the history of mesh litigation provides a clear framework for what we fight for.

• Pelvic Mesh: Over $8 billion has been paid to more than 100,000 women globally.
• Hernia Mesh (BD/Bard): In October 2024, Becton Dickinson agreed to settle approximately 40,000 cases for an estimated $1 billion or more.
• Individual Verdicts: We have seen verdicts like the $4.8 million Rhode Island award against C.R. Bard for a Ventralex mesh failure.

In South Carolina, we seek “full and fair” compensation for economic and non-economic damages. This includes:

1. Medical Expenses: The cost of the original surgery, all revision surgeries, and future reconstruction needs (like a DIEP or TRAM flap).
2. Lost Wages: Time missed from work in Columbia or Greenville due to recovery or permanent disability.
3. Pain and Suffering: The physical agony of chronic infection and the emotional toll of permanent disfigurement.
4. Loss of Consortium: The impact on your relationship with your spouse or partner.

At Attorney911, we operate on a contingency fee basis. This means we take all the financial risk. We pay for the experts, the filing fees, and the document retrieval. If we don’t recover money for you, you owe us nothing. No fee unless we win.

The Lupe Peña and Ralph Manginello Advantage

When you call 1-888-ATTY-911, you aren’t talking to a call center. You are talking to a firm led by Ralph Manginello, a Houston native with nearly three decades of experience, and Lupe Peña, whose background in insurance defense gives us an insider’s view of how these multi-billion-dollar companies try to lowball victims.

Hablamos Español. Lupe Peña conducts full client consultations in fluent Spanish, ensuring that South Carolina’s growing Hispanic community has direct, attorney-client communication without the need for unreliable interpreters. Whether you are in the heart of Columbia or a smaller community like Rock Hill or Spartanburg, our bilingual capability is a firm asset and a significant advantage for our clients.

We are also lead counsel in one of the most high-profile institutional liability cases in the country right now (Bermudez v. Pi Kappa Phi). Our ability to handle thirteen defendants and take on major universities and national fraternities proves that we have the structural capacity to handle mass tort litigation against medical device giants.

How to Find Which Device Was Used in Your South Carolina Surgery

One of the most common questions we hear from women in South Carolina is, “I don’t know what they put in me.” This is where our investigative team excels. We don’t wait for the hospital to offer information; we go get it.

To build your case, we need:

1. The Operative Report: This is the detailed “story” of your surgery. It should list every device used.
2. Device Implant Stickers: Hospitals are required to keep these. They contain the Brand, Lot Number, and Unique Device Identifier (UDI).
3. Pathology Slides: If you had a revision surgery or a capsulectomy at a facility in South Carolina, the tissue was sent to a lab. We can secure those slides for independent review by our oncological experts.
4. Product Literature: We cross-reference your implant date with the specific “Instructions for Use” (IFU) the manufacturer provided to your South Carolina surgeon at that time to see if the warnings were adequate.

If you don’t have these, don’t worry. When you hire us, we handle the records requests. We know the patient portals and the medical records departments at every major South Carolina health system.

The Whistleblower Evidence: What BD Didn’t Tell You

The case against products like GalaFLEX was significantly empowered by the testimony of Dr. Hooman Noorchashm. A former Medical Director at Becton Dickinson (BD), Dr. Noorchashm was terminated after raising alarm bells about the company’s safety reporting. He specifically alleged that BD withheld data about breast cancer recurrences in patients who received GalaFLEX and that the company participated in what he termed “human experimentation” by promoting off-label use without proper FDA authorization.

At Attorney911, we utilize this whistleblower data to pierces the corporate shield. When a company knows their product is failing and continues to sell it to South Carolina surgeons, that is not just a mistake—it is a compensable injury.

FAQ: Defective Breast Mesh and ADM Lawsuits in South Carolina

Is GalaFLEX approved by the FDA for “internal bra” surgery?
No. As the FDA stated in November 2023, no surgical mesh product—including GalaFLEX—is approved or cleared for breast-specific surgery. It is used off-label.

Can I sue even if I am not a breast cancer survivor?
Yes. Whether you underwent a cosmetic augmentation, a breast lift, or a reduction, if a defective mesh or ADM was used and caused injury, you have legal rights.

What if my surgery was at MUSC or Prisma Health years ago?
You may still have a case. Because many complications like BIA-ALCL or scaffold extrusion take years to develop, the discovery rule in South Carolina can often extend the time you have to file.

Is this a class action?
Most of these cases are handled as Mass Torts or Multidistrict Litigation (MDL). This means your case remains your own—your specific injuries determine your specific settlement—but the evidence-gathering is done collectively to save time and money.

If I had my mesh removed already, can I still file?
Absolutely. In fact, having the device removed provides critical evidence. If you still have the explanted device or the tissue, do not let the hospital destroy it. We can help secure a “preservation order.”

Why South Carolina Victims Choose Attorney911

We are not a “settlement mill.” We are a trial-ready firm. Our managing partner, Ralph Manginello, is an 8.2 “Excellent” rated attorney on Avvo and a member of the Pro Bono College of the State Bar of Texas. We believe in the “3x Content Multiplication” principle: we provide deep Legal Context, we draw on our years of Firm Experience, and we Contrast our depth with generalist firms who don’t even know what a 510(k) pathway is.

We are watching the Allergan BIOCELL MDL 2921 bellwether trial, currently set for October 19, 2026. This trial will be a watershed moment for breast-implant-related litigation. We ensure our South Carolina clients are positioned to leverage these national developments.

Supporting Our South Carolina Community

We acknowledge the deep disparities in South Carolina’s healthcare system. Statistics from the American Cancer Society show that Black women have a 40% higher mortality rate from breast cancer despite a lower incidence rate. In South Carolina, where these disparities are a reality, we are committed to health equity. We work with national resources like S.H.A.R.E. Cancer Support, LatinaSHARE, and The Tigerlily Foundation to ensure every woman, regardless of her background, gets the justice she deserves.

Si usted o un ser querido ha sido lesionado, Lupe Peña está aquí para ayudarle en su propio idioma. We believe clear communication is a right, not a luxury.

Take the Next Step for Your Health and Your Future

You have been through enough. The surgeries, the recovery, and now the realization that your medical device was defective. Our job at Attorney911 is to take the legal burden off your shoulders so you can focus on healing.

Whether you are in Charleston, Columbia, Greenville, Rock Hill, or any corner of South Carolina, we are your advocates. We offer:

• Free Consultations: 24/7 at 1-888-ATTY-911.
• No Upfront Costs: We pay all litigation expenses.
• Aggressive Representation: Led by Ralph Manginello and Lupe Peña.
• Bilingual Staff: Direct attorney access in Spanish.

The manufacturers have teams of expensive lawyers working to protect their profits. You deserve a team that is just as experienced, just as aggressive, and dedicated to you. Contact us today. Let us start digging into your medical records, identifying the defective device, and building the case for the compensation you need to reclaim your life.

Call 1-888-ATTY-911 (1-888-288-9911) today. We protect victims in South Carolina every single day—and we are ready to protect you.